NO911021L - Fremgangsmaate og preparat for iontoforese. - Google Patents

Fremgangsmaate og preparat for iontoforese.

Info

Publication number
NO911021L
NO911021L NO91911021A NO911021A NO911021L NO 911021 L NO911021 L NO 911021L NO 91911021 A NO91911021 A NO 91911021A NO 911021 A NO911021 A NO 911021A NO 911021 L NO911021 L NO 911021L
Authority
NO
Norway
Prior art keywords
compositions
iontophorese
preparation
delivery
iontophoretic delivery
Prior art date
Application number
NO91911021A
Other languages
English (en)
Other versions
NO911021D0 (no
Inventor
Jr Burton H Sage
James E Riviere
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/653,202 external-priority patent/US5302172A/en
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of NO911021D0 publication Critical patent/NO911021D0/no
Publication of NO911021L publication Critical patent/NO911021L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Paper (AREA)
  • Stringed Musical Instruments (AREA)
  • Control Of El Displays (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Fremgangsmåter og preparater for forbedret iontoforetisk avlevering av aktive bestanddeler.Preparatene er farmasøytisk aksepterbare preparater for iontoforetisk avlevering omfattende en avleverings-forbedrende mengde av en vasodilator og aktiv bestanddel .Fremgangsmåtene omfatter tilsetning av en avleverings-forbedrende mengde av en vasodilator til en aktiv bestanddel og avlevering ved iontoforese.
NO91911021A 1990-03-15 1991-03-14 Fremgangsmaate og preparat for iontoforese. NO911021L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49406290A 1990-03-15 1990-03-15
US07/653,202 US5302172A (en) 1990-03-15 1991-02-08 Method and composition for iontophoresis

Publications (2)

Publication Number Publication Date
NO911021D0 NO911021D0 (no) 1991-03-14
NO911021L true NO911021L (no) 1991-09-16

Family

ID=27051282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911021A NO911021L (no) 1990-03-15 1991-03-14 Fremgangsmaate og preparat for iontoforese.

Country Status (11)

Country Link
EP (1) EP0449463B1 (no)
JP (1) JPH074432B2 (no)
AT (1) ATE114466T1 (no)
AU (1) AU634867B2 (no)
DE (1) DE69105322T2 (no)
DK (1) DK0449463T3 (no)
ES (1) ES2075934T3 (no)
FI (1) FI911268L (no)
IE (1) IE64873B1 (no)
NO (1) NO911021L (no)
NZ (1) NZ237333A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2863757B2 (ja) * 1992-02-17 1999-03-03 ドラッグ デリバリー システムズ インコーポレイテッド 電気的経皮薬剤アプリケータ
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
CA2252899A1 (en) * 1996-06-12 1997-12-18 Alza Corporation Enhanced electrotransport of therapeutic agents having polybasic anionic counter-ions
US6004577A (en) * 1997-08-12 1999-12-21 Murdock; Thomas O. Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
US20060013769A1 (en) * 2004-07-16 2006-01-19 Stephen Carter Transdermal drug delivery formulations and method of determining optimal amounts of vasodilators therein
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein
US20100028406A1 (en) * 2005-08-05 2010-02-04 Universite De Geneve Topical drug delivery by iontophoresis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659714A (en) * 1984-03-27 1987-04-21 Dentsply, Ltd. Anesthetic methods for mammals

Also Published As

Publication number Publication date
FI911268A0 (fi) 1991-03-14
DE69105322D1 (de) 1995-01-12
FI911268A7 (fi) 1991-09-16
JPH074432B2 (ja) 1995-01-25
EP0449463B1 (en) 1994-11-30
DK0449463T3 (da) 1995-01-23
IE64873B1 (en) 1995-09-20
AU634867B2 (en) 1993-03-04
JPH0679004A (ja) 1994-03-22
NO911021D0 (no) 1991-03-14
EP0449463A2 (en) 1991-10-02
FI911268L (fi) 1991-09-16
IE910715A1 (en) 1991-09-25
NZ237333A (en) 1993-08-26
ES2075934T3 (es) 1995-10-16
ATE114466T1 (de) 1994-12-15
EP0449463A3 (en) 1991-12-27
AU7278591A (en) 1991-09-19
DE69105322T2 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
NO921875L (no) Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
IT1230742B (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
IL94990A0 (en) Pharmaceutical compositions for the prophylaxis and/or treatment of prostatic diseases
EG17996A (en) Benzimidazole derivative,process for its preparation,and insecticidal and/or acaricidal composition containing it as an active ingredient
FI925342A0 (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
NO963850L (no) Heterosykliske forbindelser, deres fremstilling og anvendelse
EP0723781A3 (en) Transdermal formulation of xanomeline
NO910874L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
EP0295695A3 (en) New pyrazoline derivatives and agents for treating cerebnew pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredrovascular diseases containing the same as active ingredient ient
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
NO911022D0 (no) Fremgangsmaate og preparat for oeket hudkonsentrasjon av aktive bestanddeler ved iontoforese.
AU634867B2 (en) Method and composition for iontophoresis
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
ZA979650B (en) Heterocyclic compounds, compositions and uses.
ZA979645B (en) Heterocyclic compounds, compositions and uses.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
IT8348383A0 (it) Enzima simile a pepsina da leucocito umano, procedimento per prepararlo, e composizione terapeutica che lo contiene come ingrediente attivo
HUT61017A (en) Process for producing 4-/3-(4-oxothiazolidinyl)/-butinylamine derivatives and pharmaceutical compositions comprising same as active ingredient
IT7920991A0 (it) Derivato isoindolinico, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.
CA2237643A1 (en) Therapeutic agent for acute hepatic failure
IT8026351A0 (it) Derivato della ammino-penicillina, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.